CIK 0001434647
- Non-accelerated filer
- Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205894398
- Phone
- +1 888-958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-30 | Mickle Travis C President & CEO | Gift | −18,139 | 123,217 | ||
| 2018-07-30 | Delaware Street Capital Master Fund, L.P. 10% owner | Purchase | +304,283 | $4.00 | $1.2M | 2,095,914 |
| 2018-05-31 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +525 | $6.10 | $3K | 2,100 |
| 2018-05-22 | Saluri Joseph Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-05-22 | Tierney David S Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-05-22 | Thompson Danny L Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-05-22 | Plooster Matthew R Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-05-22 | Pascoe Richard W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-05-15 | Cohen Daniel L EVP, Govt. & Public Relations | Purchase | +5,500 | $6.45 | $35K | 35,500 |
| 2018-05-15 | Cohen Daniel L EVP, Govt. & Public Relations | Purchase | +2,000 | $6.45 | $13K | 2,000 |
| 2018-05-15 | Cohen Daniel L EVP, Govt. & Public Relations | Purchase | +200 | $6.45 | $1K | 1,450 |
| 2018-05-15 | Cohen Daniel L EVP, Govt. & Public Relations | Purchase | +200 | $6.45 | $1K | 1,450 |
| 2018-03-23 | Thompson Danny L Director | Exercise or conversion | +3,333 | $4.65 | $15K | 16,666 |
| 2018-03-23 | Thompson Danny L Director | Shares withheld for taxes | −2,026 | $7.65 | $15K | 14,640 |
| 2018-03-23 | Thompson Danny L Director | Exercise or conversion · Stock Option (right to buy) | −3,333 | 0 | ||
| 2018-01-25 | Sangiovanni Timothy J. VP, Corporate Controller | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2018-01-25 | Guenther Sven EVP, Research & Development | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-25 | Cohen Daniel L EVP, Govt. & Public Relations | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-25 | Johnson Gordon K Chief Business Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-25 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 |
Page 17 of 25 · 499 trades